Faron Pharmaceuticals Oy (`Faron` or the `Company`) Director`s dealings TURKU - FINLAND, 26 April 2017- Faron Pharmaceuticals Ltd (`Faron`) (LON: FARN), the clinical stage biopharmaceutical company, announces that it has been notified that Dr Jonathan Knowles, a Non-Executive Director of the Company, acquired 1,000 ordinary shares in Faron at a price of £6.35 per share on 25 April 2017. Following these purchases, Dr Knowles holds 47,712 ordinary shares in the Company. The notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail. For more information please contact: Faron Pharmaceuticals Ltd Dr Markku Jalkanen,...
|
